Congressional pressure builds in favour of progress on CBD

Written by CBD-Intel || 17th July 2019 || Regulatory briefing |

North America

United States

Policy and Politics

Regulation and Legislation

Regulatory briefing

Attention in Washington is increasingly focused on CBD, with the US Congress striving to address regulation and the FDA promising policy action soon ...

It’s business as unusual over CBD in topsy-turvy Washington circles

Written by CBD-Intel || 15th July 2019 || Regulatory briefing |

North America

United States

Policy and Politics

Regulation and Legislation

Regulatory briefing

CBD has turned Washington upside down, with a legal expert at the conservative Heritage Foundation testifying to Congress on behalf of federalism over states’ rights and free enterprise ...

CBD-Intel regulatory news in brief

Written by CBD-Intel || 15th July 2019 || Regulatory briefing |

Australasia

Delaware

Europe

Italy

Kentucky

New Zealand

North America

South Dakota

Turkey

United States

Policy and Politics

Regulation and Legislation

Regulatory briefing

CBD-Intel brings you regulatory updates from Italy, France, Turkey, New Zealand, El Salvador, the US states of Delaware and South Dakota and the island territory of Guam ...

Call for UK authority to regulate and trial cannabis-based medicines

Written by CBD-Intel || 11th July 2019 || Regulatory briefing |

Europe

United Kingdom

Policy and Politics

Public Health and Medicine

Regulatory briefing

The UK Centre for Medical Cannabis (CMC) has called for a Cannabinoid Clinical Trials Authority to regulate and test cannabis-based medicinal products ...

CBD-Intel regulatory news in brief

Written by CBD-Intel || 11th July 2019 || Regulatory briefing |

Argentina

Estonia

Europe

Iowa

Lithuania

North America

South America

Turkey

United States

Companies

Policy and Politics

Regulation and Legislation

Regulatory briefing

An extra helping of regulatory news from CBD-Intel brings you snippets from Argentina, Turkey, Lithuania, Estonia, the US House of Representatives and the state of Iowa ...

Taxed and raided – Irish CBD sellers caught in a double jeopardy

Written by CBD-Intel || 9th July 2019 || Regulatory briefing |

Europe

Ireland

Companies

Marketing and Retailing

Regulation and Legislation

Regulatory briefing

Irish retailers have complained that their small shops have been raided by police and CBD stocks seized – even though they are also expected to pay tax on the products ...

Massachusetts upsets farmers by insisting on no CBD in food products

Written by Daniel Mollenkamp || 8th July 2019 || Regulatory briefing |

Massachusetts

North America

United States

Regulation and Legislation

Regulatory briefing

The Massachusetts Department of Agricultural Resources has confirmed that farmers and processors in the state cannot add CBD to food ingredients ...

CBD-Intel regulatory news in brief, 1st-5th July 2019

Written by CBD-Intel || 8th July 2019 || Regulatory briefing |

Belgium

Europe

Germany

Italy

Kansas

Massachusetts

New York

North America

United States

Regulation and Legislation

Regulatory briefing

This week’s round-up of regulatory news in the global CBD market includes updates from US federal authorities, Kansas, Massachusetts, New York City, Belgium, Germany and Italy ...

UK health committee says more research will lead to greater trust

Written by CBD-Intel || 4th July 2019 || Regulatory briefing |

Europe

United Kingdom

Policy and Politics

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

A group of British MPs is recommending that more trials and research are carried out into cannabis-based medical products (CBMPs), including those containing CBD ...

Health Canada opens consultation on prescription-free CBD health products

Written by CBD-Intel || 4th July 2019 || Regulatory briefing |

Canada

North America

Policy and Politics

Regulation and Legislation

Regulatory briefing

The Canadian government has taken a first step towards allowing health products containing CBD – and potentially other cannabinoids – without a prescription ...

Pyramid seller and UK regulator stay relaxed over reps’ unauthorised claims

Written by Freddie Dawson || 1st July 2019 || Regulatory briefing |

Europe

United Kingdom

Companies

Marketing and Retailing

Regulation and Legislation

Regulatory briefing

UK authorities may take no action, and US multi-level marketing company HempWorx will not discipline its British affiliate sellers, over online posts making health claims ...

CBD-Intel regulatory news in brief, 24th-28th June

Written by CBD-Intel || 1st July 2019 || Regulatory briefing |

Canada

Delaware

EU

Europe

Florida

Germany

Iowa

North America

Oregon

Turkey

United States

Regulation and Legislation

Regulatory briefing

A round-up of the week’s relevant regulatory news in the global CBD market for CBD-Intel, with updates from the US, Canada, EU, Germany, Turkey and the United Nations ...

USDA counsel says states cannot halt transport of legally-grown hemp

Written by Daniel Mollenkamp || 25th June 2019 || Regulatory briefing |

Colorado

Idaho

North America

Oregon

United States

West Virginia

Regulation and Legislation

Regulatory briefing

US states and tribal territories have no right to stop the transportation of legal hemp that conforms with US Department of Agriculture (USDA) guidelines or was produced under the terms of the 2014 Farm Bill ...

CBD-Intel regulatory news in brief, 17th-21st June

Written by CBD-Intel || 24th June 2019 || Regulatory briefing |

Belgium

Colombia

Europe

Florida

France

Latvia

Massachusetts

New Mexico

North America

North Dakota

Oregon

South America

United States

Policy and Politics

Regulation and Legislation

Regulatory briefing

A round-up of the week’s relevant regulatory news in the global CBD market for CBD-Intel, with updates from around the US, Belgium, France, Latvia, and Colombia ...

Sweden’s Supreme Court rules any trace of THC makes CBD a narcotic

Written by CBD-Intel || 19th June 2019 || Regulatory briefing |

Europe

Sweden

Regulation and Legislation

Regulatory briefing

In a potentially serious blow to businesses and users in Sweden, CBD oil containing low levels of THC will be classed as a narcotic following a ruling by the Swedish Supreme Court ...

Euro confusion could take vital CBD off the shelves, expert warns

Written by CBD-Intel || 19th June 2019 || Regulatory briefing |

EU

Europe

United Kingdom

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

A murky legal situation and lack of government direction continue to hold back CBD in the UK and Europe, according to a keynote speaker at next month’s Europe CBD Expo in London ...

South Africa legalises lower doses of CBD – but only for a trial year

Written by CBD-Intel || 18th June 2019 || Regulatory briefing |

Africa

South Africa

Policy and Politics

Regulation and Legislation

Regulatory briefing

A landmark decision by South Africa's now former health minister Aaron Motsoledi has legalised lower dosage CBD. But there's a catch – the ruling only applies until May 2020 ...

FDA considers the question of routes to market for non-pharma CBD

Written by Freddie Dawson || 18th June 2019 || Regulatory briefing |

North America

United States

Regulation and Legislation

Regulatory briefing

The US FDA has confirmed its commitment to creating an alternative route to market for non-pharmaceutical CBD products such as foods and dietary supplements – eventually ...

CBD regulatory news in brief,
10th-16th June 2019

Written by CBD-Intel || 17th June 2019 || Regulatory briefing |

Australasia

Australia

Brazil

Canada

Colombia

Croatia

Europe

Germany

Illinois

Louisiana

Luxemburg

Nebraska

Nevada

North America

Oregon

Portugal

South America

Texas

United States

Regulation and Legislation

Regulatory briefing

A round-up of the week’s relevant regulatory news in the global CBD market for CBD-Intel ...

Relabelling to sidestep novel food rules could be a risky business

Written by CBD-Intel || 13th June 2019 || Regulatory briefing |

Austria

Bulgaria

Czech Republic

EU

Europe

Germany

Companies

Regulation and Legislation

Regulatory briefing

Some European makers of CBD products have come up with a way to dodge requirements for novel foods – relabelling. But critics warn that could be risky ...

CBD to help with sleep, OCD, and cocaine use? Science news in brief

Written by CBD-Intel || 13th June 2019 || Regulatory briefing |

Canada

Europe

New York

North America

Spain

United States

Washington

Public Health and Medicine

Technology and Innovation

Regulatory briefing

Recent studies show cannabinoids could help with sleep disorders, obsessive compulsive disorder (OCD), and cocaine addiction, while genetic research could help regulators delineate between cannabis strains ...

CBD regulatory news in brief,
3rd-10th June

Written by CBD-Intel || 10th June 2019 || Regulatory briefing |

Alaska

EU

Europe

Germany

Louisiana

Minnesota

Nebraska

North America

North Carolina

Ohio

United States

Regulatory briefing

A round-up of the week’s relevant regulatory news in the global CBD market for CBD-Intel ...

Tilray denies failing to provide samples for UK clinical trials

Written by ECigIntelligence || 7th June 2019 || Regulatory briefing |

Europe

United Kingdom

Policy and Politics

Public Health and Medicine

Regulatory briefing

International cannabis company Tilray has denied an accusation by the British Paediatric Neurological Association that it failed to provide sample products for testing ...

Sweden tops European league for rapid alerts on CBD in food and feed

Written by CBD-Intel || 6th June 2019 || Regulatory briefing |

Austria

Czech Republic

EU

Europe

Germany

Italy

Netherlands

Poland

Spain

Sweden

Switzerland

Regulation and Legislation

Regulatory briefing

Sweden leads Europe in the number of CBD notifications submitted through the EU’s Rapid Alert System for Food and Feed (RASFF) portal ...

FDA’s big meeting leaves long road ahead shrouded in uncertainty

Written by CBD-Intel || 6th June 2019 || Regulatory briefing |

North America

United States

Policy and Politics

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

A meeting between the US FDA and members of the CBD industry provided the agency with plenty of information, but threw little light on the path it is likely to take ...

Italian supreme court bans sale of low-THC cannabis products

Written by CBD-Intel || 4th June 2019 || Regulatory briefing |

EU

Europe

Italy

Regulation and Legislation

Regulatory briefing

Italy’s Supreme Court has banned the sale of cannabis products with a THC level below 0.5%, though a further court decision is still...

CBD regulatory news in brief: worldwide, 27-31st May 2019

Written by CBD-Intel || 3rd June 2019 || Regulatory briefing |

Bulgaria

California

Connecticut

Europe

France

Germany

Italy

North America

Oregon

Texas

United States

Regulation and Legislation

Regulatory briefing

A round-up of the week’s relevant regulatory news in the global CBD market for CBD-Intel...

Bank associations pressure US Congress for cannabis banking reform

Written by Daniel Mollenkamp || 29th May 2019 || Regulatory briefing |

Alabama

Alaska

Arizona

Arkansas

California

Colorado

Connecticut

Delaware

Florida

Georgia

Hawaii

Idaho

Illinois

Indiana

Iowa

Kansas

Kentucky

Louisiana

Maine

Maryland

Massachusetts

Michigan

Minnesota

Mississippi

Missouri

Montana

Nebraska

Nevada

New Hampshire

New Jersey

New Mexico

New York

North America

North Carolina

North Dakota

Ohio

Oklahoma

Oregon

Pennsylvania

Puerto Rico

Rhode Island

South Carolina

South Dakota

Tennessee

Texas

United States

Utah

Vermont

Virginia

Washington

Washington D.C.

West Virginia

Wisconsin

Wyoming

Policy and Politics

Regulation and Legislation

Regulatory briefing

Banking associations from all across the US have written to the Senate to advocate for a hearing on cannabis banking reform ...

CBD and cannabis news in brief: regulatory worldwide, 20-27th May 2019

Written by CBD-Intel || 27th May 2019 || Regulatory briefing |

Bulgaria

California

Connecticut

Europe

France

Germany

Italy

North America

Oregon

Texas

United States

Regulation and Legislation

Regulatory briefing

A round-up of the week's relevant regulatory news in the global CBD market for CBD-Intel...

Judge’s ruling sets a precedent in patent law for cannabis extracts

Written by Daniel Mollenkamp || 24th May 2019 || Regulatory briefing |

Colorado

North America

United States

Regulation and Legislation

Regulatory briefing

Cannabinoid extracts require human intervention to change them from their natural state, a judge has ruled in a dispute that will help develop case law ...

What will European Parliament elections mean for CBD?

Written by CBD-Intel || 23rd May 2019 || Regulatory briefing |

Europe

Policy and Politics

Regulation and Legislation

Regulatory briefing

Many parties taking part in the current European parliamentary elections would like to see more research on the effects of CBD before passing pro-CBD legislation ...

US alcohol bureau won’t approve CBD-infused drinks – at least for now

Written by Daniel Mollenkamp || 20th May 2019 || Regulatory briefing |

North America

United States

Regulation and Legislation

Regulatory briefing

The US Alcohol and Tobacco Tax and Trade Bureau (ATTB) has said it will not approve the use of "hemp-CBD" in alcohol products ...

CBD and cannabis news in brief: United States

Written by CBD-Intel || 20th May 2019 || Regulatory briefing |

Colorado

Florida

Indiana

Maine

New Jersey

New York

North America

North Dakota

Tennessee

United States

Regulation and Legislation

Regulatory briefing

The first in a new weekly round-up from around the US brings you news from Colorado, Florida, Indiana, Maine, New Jersey, New York, North Dakota, and Tennessee ...

CBD and cannabis news in brief: International

Written by CBD-Intel || 20th May 2019 || Regulatory briefing |

Asia

Canada

India

North America

World

Companies

Marketing and Retailing

Policy and Politics

Regulation and Legislation

Regulatory briefing

The first in a new weekly round-up from around the world brings you news from India, Canada – and the International Space Station ...

CBD and cannabis news in brief: Europe

Written by CBD-Intel || 20th May 2019 || Regulatory briefing |

Belgium

Czech Republic

EU

Europe

Germany

Lithuania

Netherlands

Switzerland

Policy and Politics

Regulation and Legislation

Regulatory briefing

The first in a new weekly round-up from around Europe brings you news from Belgium, Germany, Switzerland, the Netherlands, the Czech Republic, Lithuania and the EU ...

Tennessee brings ‘smoking hemp’ into its legal lexicon

Written by Daniel Mollenkamp || 17th May 2019 || Regulatory briefing |

North America

Tennessee

United States

Policy and Politics

Regulation and Legislation

Regulatory briefing

The Tennessee legislature has enacted a bill which defines "smoking hemp" ...

Salvini’s bid to close down Italy’s CBD trade appears to be an empty threat

Written by CBD-Intel || 16th May 2019 || Regulatory briefing |

Europe

Italy

Marketing and Retailing

Policy and Politics

Regulation and Legislation

Regulatory briefing

The Italian CBD market should not be severely curtailed despite deputy prime minister Matteo Salvini’s threat to destroy the legal cannabis industry ...

Some fear extracts ban as Germany beefs up constraints on CBD sales

Written by CBD-Intel || 14th May 2019 || Regulatory briefing |

EU

Europe

Germany

Companies

Regulation and Legislation

Regulatory briefing

Germany is tightening controls on CBD sales in a move that may lead to a ban on hemp extracts in Europe’s largest market and which has led some chain stores to remove products from shelves ...

Police seize ‘herbal’ stock in raid on ‘UK’s first cannabis restaurant’

Written by Freddie Dawson || 13th May 2019 || Regulatory briefing |

Europe

United Kingdom

Regulation and Legislation

Regulatory briefing

Police have raided what is billed as the UK’s first cannabis restaurant, which features CBD products on its menu, seizing “a significant quantity of herbal cannabis” ...

Belgium makes smokable flower rules clear – but tax plan raises fears

Written by CBD-Intel || 13th May 2019 || Regulatory briefing |

Belgium

EU

Europe

Regulation and Legislation

Regulatory briefing

Regulations on the sale of smokable CBD flower products in Belgium have been clarified. But taxing the products like tobacco could send users to the black market, a campaign group has warned ...

New Zealand’s recreational cannabis referendum won’t affect CBD

Written by Freddie Dawson || 9th May 2019 || Regulatory briefing |

Australasia

New Zealand

Policy and Politics

Regulation and Legislation

Regulatory briefing

A decision on legalising recreational cannabis in New Zealand will go to a referendum to be held next year, but the outcome is not likely to affect the regulatory status of CBD ...

US veterans at odds with federal agency over legalising clinical trials

Written by CBD-Intel || 8th May 2019 || Regulatory briefing |

North America

United States

Policy and Politics

Public Health and Medicine

Regulatory briefing

The US Department of Veterans Affairs has opposed three CBD-related bills in Congress, leading some to wonder if the agency is looking to punish veterans who admit using medical cannabis ...

Will FDA draw a line between other CBD products and pharmaceuticals?

Written by CBD-Intel || 29th April 2019 || Regulatory briefing |

North America

United States

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

The US FDA is to hold a public hearing on 31st May on the safety of products containing cannabis or cannabis-derived compounds ― and stakeholders will be looking for a dividing line ...

When will CBD foods be legal in the US? Don’t hold your breath

Written by CBD-Intel || 25th April 2019 || Regulatory briefing |

North America

United States

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

Could CBD soon be legally sold as a dietary supplement or food in the US? The answer depends on how quickly the federal regulatory framework on cannabis in general and CBD in particular can be eased ...

Hemp growing on the rise, but Ireland still sends abroad for medical supplies

Written by CBD-Intel || 25th April 2019 || Regulatory briefing |

Europe

Ireland

Companies

Policy and Politics

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

Ireland’s Department of Health still won’t commit to allowing farmers to grow cannabis for medical use, two years after the health minister announced a medical cannabis access programme ...

Child health association ‘an obstacle to cannabis prescriptions,’ claims UK MP

Written by CBD-Intel || 24th April 2019 || Regulatory briefing |

United Kingdom

Policy and Politics

Public Health and Medicine

Regulatory briefing

A UK member of parliament has accused the president of a child healthcare organisation of lying to the parliamentary health and social care committee and dismissing the concerns of families ...

Mexican legalisation may come with added regulation and controls

Written by CBD-Intel || 18th April 2019 || Regulatory briefing |

Mexico

North America

Policy and Politics

Regulation and Legislation

Regulatory briefing

Mexico is well on its way to fully legalising cannabis and its derivative products, but the new government may impose stricter regulation than that left by the previous regime ...

Big Pharma ‘must not be allowed to set EU legal agenda on medical cannabis’

Written by CBD-Intel || 17th April 2019 || Regulatory briefing |

EU

Europe

Policy and Politics

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

Europe desperately needs harmonised legislation on medical cannabis – but it could take five years, and Big Pharma must not be allowed to set the agenda, delegates at a conference in Brussels heard ...

US attorney general favours bid to let states decide cannabis and CBD policy

Written by Daniel Mollenkamp || 16th April 2019 || Regulatory briefing |

North America

United States

Policy and Politics

Regulation and Legislation

Regulatory briefing

US attorney general William Barr has said the current patchwork regulatory situation for CBD in the country is “intolerable” and given qualified support to an act which would allow states to decide their own policies ...

Spain clears up the confusion by clamping down on CBD novel foods

Written by Elba Manzanilla Zapata || 11th April 2019 || Regulatory briefing |

EU

Europe

Spain

Regulation and Legislation

Regulatory briefing

The Spanish Agency for Consumption, Food Safety and Nutrition (AECOSAN) has issued a notice on hemp and cannabinoid use in foods, clarifying its position on European novel food regulations ...